OAM
BIO icon

Oxford Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Oxford Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,171
Closed -$378K – 269
2023
Q4 		$378K Buy
+1,171
New +$367K 0.57% 62
2020
Q1 		– Sell
-1,873
Closed -$693K – 342
2019
Q4 		$693K Buy
+1,873
New +$660K 0.02% 1064
2019
Q1 		– Sell
-1,234
Closed -$287K – 1662
2018
Q4 		$287K Sell
1,234
-3,533
-74% -$948K 0.01% 1418
2018
Q3 		$1.49M Buy
4,767
+264
+6% +$81.9K 0.03% 821
2018
Q2 		$1.31M Buy
+4,503
New +$1.24M 0.03% 897
2017
Q3 		– Sell
-3,217
Closed -$728K – 1530
2017
Q2 		$728K Buy
+3,217
New +$701K 0.01% 998
2016
Q3 		– Sell
-1,962
Closed -$281K – 773
2016
Q2 		$281K Buy
+1,962
New +$280K 0.01% 657
2016
Q1 		– Sell
-32,538
Closed -$4.53M – 800
2015
Q4 		$4.53M Sell
32,538
-66,630
-67% -$9.24M 0.11% 206
2015
Q3 		$13.3M Buy
99,168
+83,365
+528% +$12M 0.42% 37
2015
Q2 		$2.38M Buy
15,803
+14,271
+932% +$2.04M 0.06% 322
2015
Q1 		$207K Buy
+1,532
New +$190K 0.01% 606
2014
Q4 		– Sell
-2,162
Closed -$249K – 716
2014
Q3 		$249K Buy
+2,162
New +$256K 0.01% 613
2014
Q1 		– Sell
-23,339
Closed -$2.88M – 653
2013
Q4 		$2.88M Sell
23,339
-28,830
-55% -$3.51M 0.07% 350
2013
Q3 		$6.13M Sell
52,169
-7,213
-12% -$851K 0.14% 189
2013
Q2 		$6.66M Buy
+59,382
New +$6.97M 0.18% 164

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Oxford Asset Management's BIO Position: Q1 2024 in Review

Oxford Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2024, closing a stake of 1,171 shares — an estimated $378K sold.

Oxford Asset Management first reported a position in BIO in Q2 2013 and held it in 15 quarters. The position peaked at $13.3M in Q3 2015. 467 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

  • Oxford Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2024 after selling out during the quarter.
  • Oxford Asset Management sold 1,171 Bio-Rad Laboratories Class A shares in Q1 2024, an estimated $378K.
  • Oxford Asset Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 15 quarters.
  • Oxford Asset Management's Bio-Rad Laboratories Class A position peaked at $13.3M in Q3 2015.
  • 467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on Oxford Asset Management's 13F filing for Q1 2024, filed 15 May 2024.